| abstract |
Lysine mimetic compounds that are 4-amino-pyrrolidine-2-carboxylic acid analogs having the structure of Formula III, are disclosed. These compounds have useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties. Pharmaceutical compositions comprising such compounds and methods of using and making such compounds and compositions are also disclosed. (see formula III) |